Navigation Links
Centre for Sight First in the United Kingdom to Utilize TrueVision® 3D Visualization During Femtosecond Laser Cataract Surgery
Date:6/13/2013

East Grinstead, West Sussex, UK (PRWEB) June 13, 2013

TrueVision® 3D Surgical collaborated with internationally renowned eye surgeon Sheraz M. Daya, MD, FACP, FACS, FRCS(Ed), FRCOphth, to deliver a ground-breaking live educational event featuring multiple advanced technologies. Over the course of the daylong event, Dr. Daya, founder of Centre for Sight in 1996, performed four laser cataract procedures while the live 3D surgical view was streamed to the audience of visiting surgeons for an enhanced understanding of the angles and tissue depth involved in this newest form of cataract surgery.

Dr. Daya and several expert colleagues from the UK and Europe provided the audience with clinical and technical updates on the latest methods used during laser cataract surgery, as well as an open discussion about the incorporation of new technology into clinical practice. Surgical techniques, patient communication, staff education and medical economics in today’s economy were all discussed as part of the program designed to provide eye surgeons with a peer-to-peer forum for advanced cataract surgery.

“Overall, it was a tremendous event that came together due to the efforts of the Centre for Sight surgical staff and our wonderful patients, along with the support of TrueVision,” said Dr. Daya. “The feedback we have received from surgeons attending the event has been very positive and we look forward to future events that enable our colleagues to best appreciate the details of these new techniques in cataract surgery.”

TrueVision’s Clinical Director, David Friess, OD, FAAO, was on-site prior to and during the event and said that “it was terrific to see how Dr. Daya continues to be a leading innovator by adopting new technology for his patients and then sharing his experience with his colleagues in the UK.”

About TrueVision® 3D Surgical
TrueVision® 3D Surgical is the world leader in digital 3D
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. SynCardia Total Artificial Heart Featured in $3 Million Exhibition at Glasgow Science Centre
2. P&P Optica Invited to Cambridge Innovation Centre for the Canadian Technology Accelerator Program, One of Eight Canadian Life Science Companies Chosen to Participate
3. The PROOF Centre of Excellence Partners with OriGene Technologies on Heart & Kidney Transplant Biomarker Program
4. What Causes Acne? Probiotic Action Shares New Industry Insight on Why the Skin Condition Still Exists
5. How to Find the Best Acne Treatment for Every Skin Type with New Insight from Probiotic Acne Treatment, Probiotic Action
6. What Causes Acne? Adult Acne Treatment, Probiotic Action, Shares Insight on New Culprits Causing Breakouts
7. Does Dairy Cause Acne? Probiotic Action Shares New Insight on the Cause of Acne
8. Ganeden Partner Product Wins SupplySide Insights Award
9. New Remedies for Acne: Adult Acne Treatment, Probiotic Action Shares New Insight on Natural Acne Remedies
10. How to Treat Adult Acne: Adult Acne Treatment Probiotic Action Shares New Insight on Treating Breakouts for Adults
11. Adult Acne Treatment, Probiotic Action Shares Insight on Upcoming Conference on the Health Benefits of Probiotics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... BASKING RIDGE, N.J. (PRWEB) December 17, 2014 ... Ipsen (Euronext: IPN; ADR: IPSEY), ... 120 mg (referred to as Somatuline®) was approved ... for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) ... differentiated, locally advanced or metastatic disease to improve ...
(Date:12/17/2014)... 2014 Audacity, a leading California-based health ... of the Huntsworth Health Group, is proud to announce ... In her role, Gonzales will serve as Senior Vice ... honored to welcome a talent of Jamie’s caliber to ... Fraikin. “She is a proven healthcare innovation leader and ...
(Date:12/17/2014)...   Synageva BioPharma Corp. (NASDAQ: ... rare disorders, announced today its presentation at the upcoming ... San Francisco, CA. Sanj ... present on Monday, January 12, 2015, at 9:00 a.m. ... live and may be accessed from the "Webcasts & ...
(Date:12/15/2014)... Limited (NASDAQ GS: SEED) (" Origin ", or the " ... China , today announced that the Company will ... 2014, before the market opens on Thursday, January 8, 2015. ... 8, 2015, at 8:00 a.m. ET / 9:00 p.m. ... participate in the call, please dial +1-888-346-8982 in ...
Breaking Biology Technology:Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8Audacity Welcomes Healthcare Communications Expert Jamie Gonzales as Senior Vice President of Client Services 2Origin Agritech Limited to Announce Fiscal 2014 Annual Financial Results on January 8th, 2015 2Origin Agritech Limited to Announce Fiscal 2014 Annual Financial Results on January 8th, 2015 3
... 22 /PRNewswire/ - Do winery tasting rooms really help ... Vineland Research and Innovation Centre almost half of winery ... months of their visit. , "This research proves that ... the brand resulting in future sales," said Dr. Isabelle ...
... /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (TSX: AEZ; Nasdaq: ... focused on endocrine therapy and oncology, today presented ... orally-active tubulin and topoisomerase II inhibitor compound, AEZS-112, ... which may potentially provide a new therapeutic approach ...
... 500 Corporations, Universities, and Young Companies will Present at ... Mass., April 22 NSTI and CTSI today announced ... & development, funding, and commercialization partners will be showcased ... 4-6, 2009 at the George R. Brown Convention Center ...
Cached Biology Technology:Setting the Benchmark for Winery Tasting Room Research: An Emerging Region Gets a Global Perspective 2AEterna Zentaris Presents Phase 1 Results for AEZS-112 in Patients with Advanced Cancer and Lymphoma at AACR Annual Meeting in Denver 2AEterna Zentaris Presents Phase 1 Results for AEZS-112 in Patients with Advanced Cancer and Lymphoma at AACR Annual Meeting in Denver 3TechConnect Summit Brings the Global Technology Community to Houston, May 4-6, 2009 2TechConnect Summit Brings the Global Technology Community to Houston, May 4-6, 2009 3TechConnect Summit Brings the Global Technology Community to Houston, May 4-6, 2009 4
(Date:12/3/2014)... , Dec. 2, 2014 As part of ... Inception Technologies is pleased to announce the release of ... customers to collect the workforce data that they need. ... have been left by existing readers. Many such devices ... connectivity and modern technology. Older models force users to ...
(Date:11/21/2014)... Wash. , Nov. 20, 2014 C-Labs ... for the Internet of Things (IoT), today announced the ... of chief operating officer. Previously a strategic advisor to ... finance, and operations. Mr. Traynor is based out of ... . He reports to Chris Muench , Chief ...
(Date:11/18/2014)... The Parenteral Drug Association (PDA) today confirmed that seven officials ... least seven more will participate in the upcoming 2014 PDA ... Washington D.C. , Dec. 2-4. ... the regulatory agencies in the United States ... to help advance the use of metrics in the regulatory ...
Breaking Biology News(10 mins):Inception Technologies to Release New Biometric Reader 2C-Labs Names Former Microsoft and Bsquare Executive as Chief Operating Officer 2FDA's Janet Woodcock, EMA's Emer Cooke Headline PDA Quality Metrics Conference 2
... an estimated 665,000 deaths, mostly among African children. Now, ... for the world,s most useful antimalarial drug, artemisinin, giving ... cost of the live-saving drug in the future. , ... been slow due to high production costs of artemisinin. ...
... a hormone released by the lining of the stomach that ... obesity -- in fact, a vaccine that lowers ghrelin levels ... treatment for obesity. However, many people eat as a ... its effectiveness as a treatment for obesity may be reduced. ...
... pose considerable health threats to humans, and the heavy metal ... are exposed to it through plant-derived foods such as grains ... can reduce the amount of Cd found in the food ... in the Cell Press journal Trends in Plant Science ...
Cached Biology News:IU chemist develops new synthesis of most useful, yet expensive, antimalarial drug 2Low ghrelin -- reducing appetite at the cost of increased stress? 2Studies shed light on how to reduce the amount of toxins in plant-derived foods 2
VAP-1 (S-13)...
Human SPARC-like 1 Biotinylated Affinity Purified PAb...
... 4 deuterium atoms at the 3, 3', ... for use as an internal standard for ... GC- or LC-mass spectrometry. PGE2 is one ... acid and one of the most widely ...
Request Info...
Biology Products: